Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.32 |
| ▸ | BTK | Q06187 | 3/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.32 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.32 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.32 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10041346 | 0.93 | LIMK1 (0.35) | LIMK1 | |
| SCHEMBL10041330 | 0.93 | PLA2G2A (0.36) | PIK3CDBTKPIK3CAPIK3CBPIK3CG | |
| SCHEMBL10041352 | 0.93 | PLA2G2A (0.36) | PIK3CDBTKPIK3CAPIK3CBPIK3CG | |
| SCHEMBL10041328 | 0.92 | PLA2G2A (0.35) | PIK3CDBTKPIK3CAPIK3CBPIK3CG | |
| SCHEMBL9889150 | 0.89 | KDM4E (0.34) | LIMK1 | |
| SCHEMBL10348765 | 0.89 | NPC1 (0.37) | PIK3CDBTKPIK3CAPIK3CBPIK3CG | |
| SCHEMBL10348771 | 0.89 | LIMK1 (0.34) | LIMK1 | |
| SCHEMBL15855406 | 0.88 | PLA2G2A (0.36) | PIK3CDBTKPIK3CAPIK3CBPIK3CG | |
| SCHEMBL10348766 | 0.88 | NPC1 (0.36) | PIK3CDBTKPIK3CAPIK3CBPIK3CG | |
| SCHEMBL18588622 | 0.88 | PLA2G2A (0.37) | LIMK1PIK3CDBTKPIK3CAPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10355236-B2 | Transparent electrode and electronic device | Konica Minolta, Inc. (JP) | 2019-07-16 | — | — | US | disclosed |
| US-9966557-B2 | Translucent electrode, and electronic device | Konica Minolta, Inc. (JP) | 2018-05-08 | — | — | US | disclosed |
| US-9966557-B2 | Translucent electrode, and electronic device | Konica Minolta, Inc. (JP) | 2018-05-08 | — | — | US | disclosed |
| US-9947889-B2 | Transparent electrode, electronic device, and organic electroluminescent element | KONICA MINOLTA INC. (JP) | 2018-04-17 | — | — | US | disclosed |
| US-9947889-B2 | Transparent electrode, electronic device, and organic electroluminescent element | KONICA MINOLTA INC. (JP) | 2018-04-17 | — | — | US | disclosed |
| US-9923166-B2 | Transparent electrode and electronic device | Konica Minolta, Inc. (JP) | 2018-03-20 | — | — | US | disclosed |
| US-9923166-B2 | Transparent electrode and electronic device | Konica Minolta, Inc. (JP) | 2018-03-20 | — | — | US | disclosed |
| US-9876189-B2 | Transparent electrode, electronic device, and transparent electrode manufacturing method | Konica Minolta, Inc. (JP) | 2018-01-23 | — | — | US | disclosed |
| US-9876189-B2 | Transparent electrode, electronic device, and transparent electrode manufacturing method | Konica Minolta, Inc. (JP) | 2018-01-23 | — | — | US | disclosed |
| US-9871220-B2 | Transparent electrode, and electronic device | Konica Minolta, Inc. (JP) | 2018-01-16 | — | — | US | disclosed |
| US-20120261654-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE AND LIGHTING DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-10-18 | — | — | US | disclosed |
| EP-2453496-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, NOVEL COMPOUND, LIGHTING DEVICE AND DISPLAY DEVICE | Konica Minolta Holdings, Inc. (JP) | 2012-05-16 | — | — | EP | disclosed |
| US-20120037889-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, DISPLAY DEVICE AND ILLUMINATION DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-02-16 | — | — | US | disclosed |
| US-20120037889-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, DISPLAY DEVICE AND ILLUMINATION DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-02-16 | — | — | US | disclosed |
| US-20120007072-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | MERCK PATENT GMBH (DE) | 2012-01-12 | — | — | US | disclosed |
| US-20120007072-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | MERCK PATENT GMBH (DE) | 2012-01-12 | — | — | US | disclosed |
| US-20110272687-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, AND ILLUMINATION DEVICE AND DISPLAY DEVICE EACH COMPRISING THE ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-11-10 | — | — | US | disclosed |
| US-20110272687-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, AND ILLUMINATION DEVICE AND DISPLAY DEVICE EACH COMPRISING THE ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-11-10 | — | — | US | disclosed |
| US-20110006670-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-01-13 | — | — | US | disclosed |
| US-20110006670-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110006670-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME | AOC2, AOC3, CDYL | LIMK1 436/4885PIK3CD 3210/4885BTK 407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.